Notice of 2025 Annual General Meeting

AI SummaryClose X

Allergy Therapeutics plc has published its Notice of Annual General Meeting, seeking shareholder approval for two new board appointments: Helge Weiner-Trapness as Executive Director and Chief Strategy Officer, and Lawrence Allen Wang as Non-Executive Director. These appointments are intended to support the company's exploration of a dual primary listing on the Hong Kong Stock Exchange and its expansion into Asia. Mr. Weiner-Trapness brings over 30 years of experience from major investment banks, while Mr. Wang has over 20 years of healthcare and investment experience, including successfully listing Adicon on the Hong Kong Stock Exchange.

Disclaimer*

UK 100

Latest directors dealings